Flagship Ventures General Partner LLC
Insider CIK 1400249 · CNCE 10% owner · TTPH 10% owner · BIND 10% owner · TTOO 10% owner · QTRX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| QTRX Quanterix Corp | C Conversion deriv | 2017-12-11 | 2017-12-13 | 352,800 | — | $0 | 0 | SEC↗ |
| QTRX Quanterix Corp | C Conversion deriv | 2017-12-11 | 2017-12-13 | 1,533,214 | — | $0 | 0 | SEC↗ |
| QTRX Quanterix Corp | C Conversion deriv | 2017-12-11 | 2017-12-13 | 3,360,000 | — | $0 | 0 | SEC↗ |
| QTRX Quanterix Corp | C Conversion deriv | 2017-12-11 | 2017-12-13 | 1,280,000 | — | $0 | 0 | SEC↗ |
| QTRX Quanterix Corp | C Conversion | 2017-12-11 | 2017-12-13 | 398,257 | — | $0 | 398,257 | SEC↗ |
| QTRX Quanterix Corp | C Conversion | 2017-12-11 | 2017-12-13 | 1,045,426 | — | $0 | 1,443,683 | SEC↗ |
| QTRX Quanterix Corp | C Conversion | 2017-12-11 | 2017-12-13 | 477,042 | — | $0 | 1,920,725 | SEC↗ |
| QTRX Quanterix Corp | C Conversion | 2017-12-11 | 2017-12-13 | 109,770 | — | $0 | 2,030,495 | SEC↗ |
| TTOO T2 Biosystems, Inc. | C Conversion deriv | 2014-08-12 | 2014-08-14 | 819,493 | — | $0 | 0 | SEC↗ |
| TTOO T2 Biosystems, Inc. | C Conversion deriv | 2014-08-12 | 2014-08-14 | 629,851 | — | $0 | 0 | SEC↗ |
| TTOO T2 Biosystems, Inc. | C Conversion deriv | 2014-08-12 | 2014-08-14 | 631,133 | — | $0 | 0 | SEC↗ |
| TTOO T2 Biosystems, Inc. | C Conversion deriv | 2014-08-12 | 2014-08-14 | 774,527 | — | $0 | 0 | SEC↗ |
| TTOO T2 Biosystems, Inc. | C Conversion deriv | 2014-08-12 | 2014-08-14 | 1,053,201 | — | $0 | 0 | SEC↗ |
| TTOO T2 Biosystems, Inc. | C Conversion deriv | 2014-08-12 | 2014-08-14 | 128,567 | — | $0 | 0 | SEC↗ |
| TTOO T2 Biosystems, Inc. | C Conversion | 2014-08-12 | 2014-08-14 | 741,755 | — | $0 | 2,374,571 | SEC↗ |
| TTOO T2 Biosystems, Inc. | C Conversion | 2014-08-12 | 2014-08-14 | 1,632,816 | — | $0 | 1,632,816 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-19 | 3,000,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-19 | 525,500 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-19 | 93,008 | — | $0 | 656,490 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-19 | 530,974 | — | $0 | 563,482 | SEC↗ |
| BIND BIND Therapeutics, Inc | C Conversion deriv | 2013-09-25 | 2013-09-27 | 407,060 | — | $0 | 0 | SEC↗ |
| BIND BIND Therapeutics, Inc | C Conversion deriv | 2013-09-25 | 2013-09-27 | 1,900,000 | — | $0 | 0 | SEC↗ |
| BIND BIND Therapeutics, Inc | C Conversion deriv | 2013-09-25 | 2013-09-27 | 416,667 | — | $0 | 0 | SEC↗ |
| BIND BIND Therapeutics, Inc | C Conversion deriv | 2013-09-25 | 2013-09-27 | 333,288 | — | $0 | 0 | SEC↗ |
| BIND BIND Therapeutics, Inc | C Conversion deriv | 2013-09-25 | 2013-09-27 | 984,640 | — | $0 | 0 | SEC↗ |
| BIND BIND Therapeutics, Inc | C Conversion | 2013-09-25 | 2013-09-27 | 1,542,616 | — | $0 | 1,542,616 | SEC↗ |
| BIND BIND Therapeutics, Inc | P Buy | 2013-09-25 | 2013-09-27 | 20,000 | $15.00 | $300.0K | 1,562,616 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 2,090,000 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 2,726,088 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 11,422,045 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 19,544,924 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 9,626,604 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | P Buy | 2013-03-25 | 2013-03-27 | 491,824 | $7.00 | $3.44M | 1,165,786 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 673,962 | — | $0 | 673,962 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 331,953 | — | $0 | 891,887 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 393,863 | — | $0 | 559,934 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 94,003 | — | $0 | 166,071 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 72,068 | — | $0 | 72,068 | SEC↗ |